Skip to main content

Table 3 Multivariate analysis of Uganda II family and anti-TB drug resistance among sputum smear-positive TB patients in Uganda

From: The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda

Genotype

Resistance Pattern

 

Any resistance

MDR

 

Proportion

**OR

95% CI

p-value

Proportion

**OR

95% CI

p-value

Uganda II

26/422 (6.2)

Ref.

  

3/422 (0.7)

Ref.

  

Other

91/549 (16.6)

2.9

1.63-5.06

0.001

19/530 (3.5)

4.9

1.15-20.60

0.032

  1. Others included in the model were National TB/Leprosy Program (NTLP) zone, patient category (new or previously treated), HIV status, age group, and residence (rural/urban).
  2. ** Odds ratios adjusted for cluster design.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us